Signum Biosciences
{{Short description|Multi-level marketing company}}
{{Use mdy dates|date=March 2020}}
Signum Biosciences, Inc. is a dietary supplement company located in Boulder, Colorado.
History
Signum was founded in 2003 by Maxwell Stock and his father Jeffrey B. Stock in Monmouth Junction, NJ.{{cite web |website=gregorystock.net |author=Gregory Stock |url=http://www.gregorystock.net/where-are-the-new-therapeutics.asp |title=Where are the New Therapeutics? |accessdate=10 April 2015 |archiveurl=https://web.archive.org/web/20160304030809/http://www.gregorystock.net/where-are-the-new-therapeutics.asp |archivedate=4 March 2016 |url-status=dead}} In 2020 the company relocated to Boulder, Colorado.{{Cite web |date=2020-05-22 |title=Signum Biosciences developing cutting-edge health biotech in Boulder • BLDRfly |url=https://bldrfly.com/features/2020/05/22/health-technology-merge-in-boulder/ |access-date=2023-11-07 |website=BLDRfly |language=en-US}}
Signum agreed in 2019 to stop making certain claims about its EHT supplement, and to stop allowing its multi-level marketing partner firm Neora (formerly Nerium International) to make such claims.
=Neora (Nerium) partnership and FTC injunction=
In 2015 Signum partnered with Neora, LLC (then known as Nerium International) to launch a dietary supplement called eicosanoyl-5-hydroxytryptamide (EHT).{{cite web |date=10 April 2015 |url=https://www.prweb.com/releases/nerium_international_introduces_new_advanced_anti_aging_product_focused_on_optimal_brain_health/prweb12644620.htm |title=Nerium Press Release: Nerium International Introduces New, Advanced Anti-Aging Product Focused on Optimal Brain Health |access-date=27 March 2020 |archive-date=11 May 2019 |archive-url=https://web.archive.org/web/20190511100639/http://www.prweb.com/releases/2015/04/prweb12644620.htm |url-status=live}} EHT is derived from coffee and inhibits demethylation of the enzyme protein phosphatase 2 (PPP2CA; PP2A).{{cite journal |last1=Haas |first1=M. J. |title=Extracting PD therapy from coffee |journal=SciBX |date=26 May 2011 |volume=2011 |issue=590 |pages=590 |doi=10.1038/scibx.2011.590 |doi-access=free}} In October 2019 the Federal Trade Commission won a permanent injunction against Signum BioSciences, Signum Nutralogix, and affiliated companies including Neora. The injunction prohibits claims or representations of EHT's efficacy in treating or mitigating Alzheimer's disease, Parkinson's disease, or brain injury including CTE and concussion, unless those claims are backed up by randomized, double-blind, placebo-controlled human clinical testing.{{cite web |last1=DiFurio |first1=Dom |title=FTC sues Addison-based Neora for allegedly operating pyramid scheme, pushing concussion treatment |url=https://www.dallasnews.com/business/2019/11/01/ftc-sues-addison-based-neora-for-allegedly-operating-pyramid-scheme-pushing-treatment-for-cte/ |website=dallasnews.com |accessdate=27 March 2020 |archiveurl=https://web.archive.org/web/20200327151326/https://www.dallasnews.com/business/2019/11/01/ftc-sues-addison-based-neora-for-allegedly-operating-pyramid-scheme-pushing-treatment-for-cte/ |archivedate=27 March 2020 |date=1 Nov 2019 |url-status=live}}{{cite web |last1=Notopoulos |first1=Katie |title=The FTC Said This Skincare Line Is A Pyramid Scheme |url=https://www.buzzfeednews.com/article/katienotopoulos/ftc-neora-skincare-pyramid-scheme-mlm |website=buzzfeednews.com |accessdate=27 March 2020 |archiveurl=https://web.archive.org/web/20200327152215/https://www.buzzfeednews.com/article/katienotopoulos/ftc-neora-skincare-pyramid-scheme-mlm |archivedate=27 March 2020 |date=6 November 2019 |url-status=live}}
External links
- [https://signumbiosciences.com/ Company site]